ʻO ka Papa Laʻau Lapaʻau Maʻemaʻe Kiʻekiʻe 877399-52-5 Crizotinib no ka Lapaʻau Anti-cancer

ʻO ka wehewehe pōkole:

Maʻemaʻe:≧99%, Keʻokeʻo i ka pauka crystalline keʻokeʻo

Kūlana Kūlana:In-House a i ʻole e like me ka makemake

Kaha:50Kgs/Mahina

Ke ola papa:3 Makahiki

Noi:He ʻano lāʻau lapaʻau i manaʻo ʻia;no ka ma'i 'a'ai ma'i ma'i 'ole li'ili'i

Pōmaikaʻi Hui:ʻO ka hui kūʻai hoʻokuʻu aku ʻike me ka hoʻomaʻamaʻa ʻoihana ma ka hale hana

E hoʻouna i ka leka uila iā mākou Hoʻoiho ma ke ʻano he PDF

Huahana Huahana

FAQ

Huahana Huahana

Huahanainoa	ʻO Crizotinib
Nā huaʻōlelo like	PF-02341066;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine;PF 2341066
CAS No.	877399-52-5
Ka nana aku	Keʻokeʻo a keʻokeʻo keʻokeʻo crystalline pauda
ʻĀpana Molekala	C₂₁H₂₂Cl₂FN₅O
Kaumaha Molekala	450.34
Hoʻohana	Lapaʻau Lapaʻau a i ʻole ke kumu noiʻi
Hoʻopili	E like me kāu noi
Waihona	E mālama i loko o nā pahu paʻa a me ka māmā ma kahi anuanu

ʻO CrizotinibKa helu helu: 877399-52-5
Nā mea	Nā kikoʻī	Nā hualoaʻa
Ka nana aku	Keʻokeʻo a keʻokeʻo keʻokeʻo crystalline pauda	ʻO ka pauka kristal keʻokeʻo
ʻIkepili	H-NMR, MS	Hoʻokō
Nā mea hoʻoheheʻe koena	isopropanol≤0.5% EtOAc≤0.5% THF≤0.072% n-Heptane≤0.5% Toluene≤0.5%	0.3% ND ND ND ND ND
Metala Kaumaha	≤10ppm	Hoʻokō
ʻAno wai	£0.5%	0.3%
Ke koena ma ka ʻā	£0.5%	0.05%
Enantiomer	£0.1%	＜LOQ
ʻO ka haumia pili e HPLC	Hoʻokahi haumia≤0.1% Huina haumia ≤1.0%	0.05% 0.12%
Maʻemaʻe (HPLC)	³99.0%	99.88%

ʻIkepili Hui

√ Ka ʻike piha o ka papa hoʻokele ma ka hale hana a me nā mea ʻenehana akamai;
√ ʻO ka maikaʻi ka mea i manaʻo nui ʻia, ʻōnaehana QC koʻikoʻi;
√ 11 makahiki i ʻike i ka lawe ʻana i nā hui kūʻai;
√ Keʻena hana R&D kūʻokoʻa;
√ ʻElua mau papa hana GMP lōʻihi i pūlima ʻia;
√ Nā waiwai waiwai o nā hale hana palaualelo no ka papahana maʻamau;
√ Kiʻekiʻe Efficiency hui hana me ke ala mau.
imgsaf